Evidence map›Paper›PMID 32506137›Full record

ArticleNeuro-oncology2020

MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry.

James L Leach, James Roebker, Austin Schafer, Joshua Baugh, Brooklyn Chaney, Christine Fuller, Maryam Fouladi, Adam Lane, Renee Doughman, Rachid Drissi and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Cerebrospinal Fluid-Derived Genomic Alterations Tracking Glioma.Journal of molecular neuroscience : MN · 2025
    Article
  9. Review
  10. Pediatric diffuse intrinsic pontine gliomas- a prospective observational study from a tertiary care neurosurgical center.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Observational
  11. Article
  12. Article
  13. Reirradiation for diffuse intrinsic pontine glioma: prognostic radiomic factors at progression.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Article
  14. Article
  15. Article
  16. Case Report: Low-grade glioma withFrontiers in surgery · 2024
    Article
  17. Article
  18. Review
  19. Review
  20. Fifty years of DIPG: looking at the future with hope.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 3 countries.

James L LeachDepartment of Radiology and Medical Imaging, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
James RoebkerDepartment of Radiology and Medical Imaging, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Austin SchaferCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Joshua BaughCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Brooklyn ChaneyCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Christine FullerDepartment of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Maryam FouladiCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Adam LaneCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Renee DoughmanCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Rachid DrissiCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Mariko DeWire-SchottmillerCancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
David S ZieglerKids Cancer Centre, Sydney Children's Hospital, Sydney, AU.
Jane E MinturnDivision of Oncology, Children's Hospital of Philadelphia, Pennsylvania.
Jordan R HansfordChildren's Cancer Centre, Royal Children's Hospital; Murdoch Children's Research Institute; University of Melbourne, Melbourne, Australia.
Stacie S WangChildren's Cancer Centre, Royal Children's Hospital; Murdoch Children's Research Institute; University of Melbourne, Melbourne, Australia.
Michelle Monje-DeisserothDepartment of Neurology and Neurological Sciences, Stanford University, Palo Alto, California.
Paul G FisherDepartment of Neurology and Neurological Sciences, Stanford University, Palo Alto, California.
Nicholas G GottardoDepartment of Oncology, Perth Children's Hospital, Perth, AU.
Hetal DholariaDepartment of Oncology, Perth Children's Hospital, Perth, AU.
Roger PackerDivision of Oncology, Children's National Medical Center, Washington, DC.
Katherine WarrenDana-Farber Cancer Institute, Boston Children's Cancer and Blood Disorders Center, Harvard Cancer Center, Boston Massachusetts.
Sarah E S LearyCancer and Blood Disorders Center, Seattle Children's, Seattle, Washington.
Stewart GoldmanDivision of Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Ute BartelsDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, CA.
Cynthia HawkinsDivision of Pathology, The Hospital for Sick Children, Toronto, CA.
Blaise V JonesDepartment of Radiology and Medical Imaging, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Cincinnati Children's Hospital Medical Center · USPrincess Margaret Hospital for Children · AURoyal Children's Hospital · AUStanford University · USCenter for Cancer and Blood Disorders · USChildren's Hospital of Philadelphia · USChildren's National · USDana-Farber Cancer Institute · USLurie Children's Hospital · USSydney Children's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study describes imaging features of diffuse intrinsic pontine glioma (DIPG) and correlates with overall survival (OS) and histone mutation status in the International DIPG Registry (IDIPGR).

methodsFour hundred cases submitted to the IDIPGR with a local diagnosis of DIPG and baseline MRI were evaluated by consensus review of 2 neuroradiologists; 43 cases were excluded (inadequate imaging or alternative diagnoses). Agreement between reviewers, association with histone status, and univariable and multivariable analyses relative to OS were assessed.

resultsOn univariable analysis imaging features significantly associated with worse OS included: extrapontine extension, larger size, enhancement, necrosis, diffusion restriction, and distant disease. On central review, 9.5% of patients were considered not to have DIPG. There was moderate mean agreement of MRI features between reviewers. On multivariable analysis, chemotherapy, age, and distant disease were predictors of OS. There was no difference in OS between wild-type and H3 mutated cases. The only imaging feature associated with histone status was the presence of ill-defined signal infiltrating pontine fibers.

conclusionsBaseline imaging features are assessed in the IDIPGR. There was a 9.5% discordance in DIPG diagnosis between local and central review, demonstrating need for central imaging confirmation for prospective trials. Although several imaging features were significantly associated with OS (univariable), only age and distant disease were significant on multivariable analyses. There was limited association of imaging features with histone mutation status, although numbers are small and evaluation exploratory.

Indexed as

Brain Stem NeoplasmsDiffuse Intrinsic Pontine GliomaHumansMagnetic Resonance ImagingProspective StudiesRegistriesdiffuse midline gliomaDIPGhistone mutationinternational DIPG registryMRI

Identifiers

PMID32506137
PMCPMC7690352
OpenAlexW3033288987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.